EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functionalizing Injectable Hydrogels with Cobalt‐Based Metallacarboranes for Targeted Delivery in Triple‐Negative Breast Cancer

Neville Murphy iD, Roberto González-Gómez iD, Nivethitha Ashok, Enda O'Connell iD, Howard Fearnhead iD, William J Tipping iD, Karen Faulds iD, Wenming Tong iD, Abhay Pandit iD, Róisín M Dwyer iD, Duncan Graham iD, Pau Farràs iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202500589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Neville Murphy und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Chemical Sciences, Ryan Institute, University of Galway, H91 CF50, Galway, Ireland. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cobalt, Hydrogels, Antineoplastic Agents. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Ireland, National Breast Cancer Research Institute, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cobalt‐based metallacarboranes have emerged as potential candidates for cancer treatment owing to their unique structural properties. In this study, a biocompatible delivery platform is developed by noncovalently incorporating cobalt metallacarborane (CoSAN) into hyaluronic acid (HA) functionalized with lysine (Lys). HA‐Lys 2 enables the electrostatic interaction of CoSAN while retaining its cytotoxic activity, as confirmed by cellular assays using MDA‐MB‐231 triple‐negative breast cancer cells. Elemental mapping via energy‐dispersive X‐ray spectroscopy (EDX) confirms the successful and homogeneous incorporation of CoSAN to lead HA‐Lys‐CoSAN 3 , and the composite is further characterized using diffusion‐ordered nuclear magnetic resonance (NMR) spectroscopy (DOSY). Stimulated Raman scattering (SRS) microscopy data demonstrate comparable cellular uptake in MDA‐MB‐231 cells of free and HA‐loaded CoSAN. Additionally, release studies under physiologically relevant conditions show a sustained release profile over 24 h with pH dependency to mimic normal and tumor microenvironments. The present study describes a viable method for integrating metallacarboranes into a polymeric drug delivery system without compromising their anticancer properties, thereby advancing their potential for future therapeutic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCobaltHydrogelsAntineoplastic AgentsDrug Delivery SystemsDrug CarriersBoranesHumansCell Line, TumorHyaluronic AcidFemaleCell SurvivalCell Proliferation

Stichwörter der Autor:innen

cobalt–bis(dicarbollide)hyaluronic acidmetallacarboranestargeted delivery systemstriple‐negative breast cancer

Substanzen

CobaltHydrogelsAntineoplastic AgentsHyaluronic AcidDrug CarriersBoranes

Autor:innen und Institutionen

  • School of Biological and Chemical Sciences, Ryan Institute, University of Galway, H91 CF50, Galway, Ireland.
  • CÚRAM Research Ireland Centre for Medical Devices, University of Galway, H91 W2TY, Galway, Ireland.
  • Genomics and Screening Core, University of Galway, H91 W2TY, Galway, Ireland.
  • Pharmacology and Therapeutics, University of Galway, H91 TK33, Galway, Ireland.
  • Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, G1 1RD, UK.
  • Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33, Galway, Ireland.

ORCID-Profile: Neville Murphy, Roberto González-Gómez, Enda O'Connell, Howard Fearnhead, William J Tipping, Karen Faulds, Wenming Tong, Abhay Pandit, Róisín M Dwyer, Duncan Graham, Pau Farràs

Förderung

  • Research Ireland
  • National Breast Cancer Research Institute
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Murphy, N., González-Gómez, R., Ashok, N., O'Connell, E., Fearnhead, H., Tipping, W. J., Faulds, K., Tong, W., Pandit, A., Dwyer, R. M., Graham, D., & Farràs, P. (2025). Functionalizing Injectable Hydrogels with Cobalt‐Based Metallacarboranes for Targeted Delivery in Triple‐Negative Breast Cancer. ChemBioChem. https://doi.org/10.1002/cbic.202500589

Vancouver

Murphy N, González-Gómez R, Ashok N, O'Connell E, Fearnhead H, Tipping WJ, et al. Functionalizing Injectable Hydrogels with Cobalt‐Based Metallacarboranes for Targeted Delivery in Triple‐Negative Breast Cancer. ChemBioChem. 2025. doi:10.1002/cbic.202500589

BibTeX
@article{Murphy2025,
  author = {Murphy, Neville and González-Gómez, Roberto and Ashok, Nivethitha and O'Connell, Enda and Fearnhead, Howard and Tipping, William J and Faulds, Karen and Tong, Wenming and Pandit, Abhay and Dwyer, Róisín M and Graham, Duncan and Farràs, Pau},
  title = {Functionalizing Injectable Hydrogels with Cobalt‐Based Metallacarboranes for Targeted Delivery in Triple‐Negative Breast Cancer},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202500589}
}
Kostenlos starten →